Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and NRF2 transcription factors

Details for Australian Patent Application No. 2009296743 (hide)

Owner Bach Pharma Inc.

Inventors Henry, Mark O.; Lynn, William S.

Agent Shelston IP

Pub. Number AU-A-2009296743

PCT Pub. Number WO2010/036711

Priority 61/099,456 23.09.08 US; 61/150,581 06.02.09 US

Filing date 23 September 2009

Wipo publication date 1 April 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/036711 Priority application(s): WO2010/036711

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296744-Selective data forwarding storage

2009296740-Remote device control and power supply